Canada Markets close in 6 hrs 25 mins

Oncolytics Biotech Inc. (ONC.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
2.1000-0.0100 (-0.47%)
As of 09:30AM EST. Market open.
Currency in CAD

Valuation Measures4

We’re sorry, we weren’t able to find any data.
Please try reloading the page.

Trading Information

Stock Price History

Beta (5Y Monthly) 1.81
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 36.0600
52 Week Low 31.9700
50-Day Moving Average 32.5166
200-Day Moving Average 33.2554

Share Statistics

Avg Vol (3 month) 366.92k
Avg Vol (10 day) 385.43k
Shares Outstanding 552.77M
Implied Shares Outstanding 6N/A
Float 854.1M
% Held by Insiders 11.31%
% Held by Institutions 11.93%
Shares Short (Sep. 14, 2021) 446.52k
Short Ratio (Sep. 14, 2021) 40.76
Short % of Float (Sep. 14, 2021) 40.09%
Short % of Shares Outstanding (Sep. 14, 2021) 40.08%
Shares Short (prior month Aug. 12, 2021) 4184.26k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 24, 2018
Ex-Dividend Date 4N/A
Last Split Factor 2105:1000
Last Split Date 3May 24, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Jun. 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-37.14%
Return on Equity (ttm)-84.45%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -26.87M
Net Income Avi to Common (ttm)-29.76M
Diluted EPS (ttm)-0.5600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)50.8M
Total Cash Per Share (mrq)0.92
Total Debt (mrq)744.51k
Total Debt/Equity (mrq)1.60
Current Ratio (mrq)21.47
Book Value Per Share (mrq)0.54

Cash Flow Statement

Operating Cash Flow (ttm)-24.22M
Levered Free Cash Flow (ttm)-14.51M